Results: 1-25 | 26-28
Results: 1-25/28

Authors: Potapov, EV Nasseri, BA Loebe, M Kukucka, M Koster, A Kuppe, H Noon, GP DeBakey, ME Hetzer, R
Citation: Ev. Potapov et al., Transcranial detection of microembolic signals in patients with a novel nonpulsatile implantable LVAD, ASAIO J, 47(3), 2001, pp. 249-253

Authors: Loebe, M Koster, A Sanger, S Potapov, EV Kuppe, H Noon, GP Hetzer, R
Citation: M. Loebe et al., Inflammatory response after implantation of a left ventricular assist device: Comparison between the axial flow MicroMed DeBakey VAD and the pulsatile Novacor device, ASAIO J, 47(3), 2001, pp. 272-274

Authors: Koster, A Loebe, M Sodian, R Potapov, EV Hansen, R Muller, J Mertzlufft, F Crystal, GJ Kuppe, H Hetzer, R
Citation: A. Koster et al., Heparin antibodies and thromboembolism in heparin-coated and noncoated ventricular assist devices, J THOR SURG, 121(2), 2001, pp. 331-335

Authors: Pasic, M Bergs, P Muller, P Hofmann, M Grauhan, O Kuppe, H Hetzer, R
Citation: M. Pasic et al., Intraoperative radiofrequency maze ablation for atrial fibrillation: The Berlin modification, ANN THORAC, 72(5), 2001, pp. 1484-1490

Authors: Dietrich, W Spath, P Zuhlsdorf, M Dalichau, H Kirchhoff, PG Kuppe, H Preiss, DU Mayer, G
Citation: W. Dietrich et al., Anaphylactic reactions to aprotinin reexposure in cardiac surgery - Relation to antiaprotinin immunoglobulin G and E antibodies, ANESTHESIOL, 95(1), 2001, pp. 64-71

Authors: Koster, A Kulucka, M Bach, F Meyer, O Fischer, T Mertzlufft, F Loebe, M Hetzer, R Kuppe, H
Citation: A. Koster et al., Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban, ANESTHESIOL, 94(2), 2001, pp. 245-251

Authors: Redlin, M Werner, J Habazettl, H Griethe, W Kuppe, H Pries, AR
Citation: M. Redlin et al., Cariporide (HOE 642) attenuates leukocyte activation in ischemia and reperfusion, ANESTH ANAL, 93(6), 2001, pp. 1472-1479

Authors: Koster, A Sanger, S Hansen, R Sodian, R Mertzlufft, F Harke, C Kuppe, H Hetzer, R Loebe, M
Citation: A. Koster et al., Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices, ASAIO J, 46(3), 2000, pp. 319-322

Authors: Koster, A Hansen, R Kuppe, H Hetzer, R Crystal, GJ Mertzlufft, F
Citation: A. Koster et al., Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: A 1-year experience in 57 patients, J CARDIOTHO, 14(3), 2000, pp. 243-248

Authors: Koster, A Hansen, R Grauhan, O Hausmann, H Bauer, M Hetzer, R Kuppe, H Mertzlufft, F
Citation: A. Koster et al., Hirudin monitoring using the TAS ecarin clotting time in patients with heparin-induced thrombocytopenia type II, J CARDIOTHO, 14(3), 2000, pp. 249-252

Authors: Koster, A Crystal, GJ Kuppe, H Mertzlufft, F
Citation: A. Koster et al., Acute heparin-induced thrombocytopenia type II during cardiopulmonary bypass, J CARDIOTHO, 14(3), 2000, pp. 300-303

Authors: Mertzlufft, F Kuppe, H Koster, A
Citation: F. Mertzlufft et al., Management of urgent high-risk cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and coexisting disorders of renal function: Use of heparin and epoprostenol combined with on-line monitoring of platelet function, J CARDIOTHO, 14(3), 2000, pp. 304-308

Authors: Koster, A Meyer, O Hausmann, H Kuppe, H Hetzer, R Mertzlufft, F
Citation: A. Koster et al., In vitro cross-reactivity of danaparoid sodium in patients with heparin-induced thrombocytopenia type II undergoing cardiovascular surgery, J CLIN ANES, 12(4), 2000, pp. 324-327

Authors: Koster, A Loebe, M Hansen, R Bauer, M Mertzlufft, F Kuppe, H Hetzer, R
Citation: A. Koster et al., A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: Adaptation of the ecarin clotting time to the ACT II device, J THOR SURG, 119(6), 2000, pp. 1278-1283

Authors: Pasic, M Potapov, E Kuppe, H Hetzer, R
Citation: M. Pasic et al., Prolonged cardiopulmonary bypass for severe drug intoxication, J THOR SURG, 119(2), 2000, pp. 379-380

Authors: Pasic, M Ewert, R Engel, M Franz, N Bergs, P Kuppe, H Hetzer, R
Citation: M. Pasic et al., Aortic rupture and concomitant transection of the left bronchus after blunt chest trauma, CHEST, 117(5), 2000, pp. 1508-1510

Authors: Potapov, EV Loebe, M Nasseri, BA Sinawski, H Koster, A Kuppe, H Noon, GP DeBakey, ME Hetzer, R
Citation: Ev. Potapov et al., Pulsatile flow in patients with a novel nonpulsatile implantable ventricular assist device, CIRCULATION, 102(19), 2000, pp. 183-187

Authors: Koster, A Loebe, M Mertzlufft, F Kuppe, H Hetzer, R
Citation: A. Koster et al., Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant, ANN THORAC, 70(6), 2000, pp. 2160-2161

Authors: Koster, A Loebe, M Hansen, R Potapov, EV Noon, GP Kuppe, H Hetzer, R
Citation: A. Koster et al., Alterations in coagulation after implantation of a pulsatile Novacor LVAD and the axial flow MicroMed DeBakey LVAD, ANN THORAC, 70(2), 2000, pp. 533-537

Authors: Koster, A Pasic, M Bauer, M Kuppe, H Hetzer, R
Citation: A. Koster et al., Hirudin as anticoagulant for cardiopulmonary bypass: Importance of preoperative renal function, ANN THORAC, 69(1), 2000, pp. 37-41

Authors: Mertzlufft, F Koster, A Hansen, R Risch, A Kuppe, H Kubel, B Crystal, GJ
Citation: F. Mertzlufft et al., Reliability of the heparin management test for monitoring high levels of unfractionated heparin - In vitro findings in volunteers versus in vivo findings during cardiopulmonary bypass, ANESTHESIOL, 92(6), 2000, pp. 1594-1602

Authors: Hansen, R Koster, A Kukucka, M Mertzlufft, F Kuppe, H
Citation: R. Hansen et al., A quick anti-Xa-activity-based whole blood coagulation assay for monitoring unfractionated heparin during cardiopulmonary bypass: A pilot investigation, ANESTH ANAL, 91(3), 2000, pp. 533-538

Authors: Koster, A Merkle, F Hansen, R Loebe, M Kuppe, H Hetzer, R Crystal, GJ Mertzlufft, F
Citation: A. Koster et al., Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: Assessment of different filter systems, ANESTH ANAL, 91(2), 2000, pp. 265-269

Authors: Koster, A Kuppe, H Crystal, GJ Mertzlufft, F
Citation: A. Koster et al., Cardiovascular surgery without cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II using anticoagulation with recombinant hirudin, ANESTH ANAL, 90(2), 2000, pp. 292-298

Authors: Musci, M Pasic, M Meyer, R Loebe, M Wellnhofer, E Weng, Y Kuppe, H Hetzer, R
Citation: M. Musci et al., Coronary artery bypass grafting after orthotopic heart transplantation, EUR J CAR-T, 16(2), 1999, pp. 163-167
Risultati: 1-25 | 26-28